EUVIMEDEUVIMED entdecken
FallberichtOpen Access

New Phenotypic Features in FGFR1 ‐Related Osteoglophonic Dysplasia

Amna A Othman iD, Holly E Babcock, Corey S Gill, Jamie L Fraser, Debra S Regier, Rajdeep Kaur, Kara L Simpson, Carlos R Ferreira

American Journal of Medical Genetics Part A · 2025

DOI: 10.1002/ajmg.a.64092 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Amna A Othman und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Bone Diseases, Developmental, Phenotype, Receptor, Fibroblast Growth Factor, Type 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoglophonic dysplasia (OGD) is a rare skeletal disorder caused by certain variants in FGFR1 . The FGFR1 gene encodes a receptor vital for osteogenesis in the axial and craniofacial skeleton. Key OGD features include craniosynostosis, craniofacial dysmorphism, impacted teeth, rhizomelic shortening, and nonossifying fibromas. Patients may have hypophosphatemia due to high FGF23 levels. We report two OGD patients with the c.1141T > C FGFR1 variant [p.(Cys381Arg)], initially diagnosed with Pfeiffer syndrome. Both showed classic symptoms as well as signs not previously reported, including elevated frontal temperature and overlapping toes. This report emphasizes distinguishing OGD from similar disorders and expanding the clinical phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Diseases, DevelopmentalPhenotypeReceptor, Fibroblast Growth Factor, Type 1Child, PreschoolFemaleHumansMaleFibroblast Growth Factor-23MutationChild

Stichwörter der Autor:innen

FGFR1craniosynostosishypophosphatemiaimpacted teethnonossifying fibromasosteoglophonic dysplasiaskeletal dysplasia

Substanzen

FGF23 protein, humanFGFR1 protein, humanFibroblast Growth Factor-23Receptor, Fibroblast Growth Factor, Type 1

Autor:innen und Institutionen

  • National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Unit on Skeletal Genomics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Orthopedic Surgery, University of Texas Southwestern Medical Center and Scottish Rite for Children, Dallas, Texas, USA.
  • Prenatal Pediatrics Institute, Children's National Hospital, Washington, DC, USA.
  • Center for Genetic Medicine Research, Children's National Hospital, Washington, DC, USA.
  • Division of Genetics and Metabolism, Children's National Hospital, Washington, DC, USA.

ORCID-Profile: Amna A Othman

Förderung

  • Intramural NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Othman, A. A., Babcock, H. E., Gill, C. S., Fraser, J. L., Regier, D. S., Kaur, R., Simpson, K. L., & Ferreira, C. R. (2025). New Phenotypic Features in FGFR1 ‐Related Osteoglophonic Dysplasia. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64092

Vancouver

Othman AA, Babcock HE, Gill CS, Fraser JL, Regier DS, Kaur R, et al. New Phenotypic Features in FGFR1 ‐Related Osteoglophonic Dysplasia. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64092

BibTeX
@article{Othman2025,
  author = {Othman, Amna A and Babcock, Holly E and Gill, Corey S and Fraser, Jamie L and Regier, Debra S and Kaur, Rajdeep and Simpson, Kara L and Ferreira, Carlos R},
  title = {New Phenotypic Features in FGFR1 ‐Related Osteoglophonic Dysplasia},
  journal = {American Journal of Medical Genetics Part A},
  year = {2025},
  doi = {10.1002/ajmg.a.64092}
}
Kostenlos starten →